Global GLP-1 Autoinjectors Market Growth 2026-2032

July 2026 | 111 pages | ID: G4E2B5AF2F18EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global GLP-1 Autoinjectors market size is predicted to grow from US$ 4226 million in 2025 to US$ 7357 million in 2032; it is expected to grow at a CAGR of 8.5% from 2026 to 2032.

GLP-1 autoinjectors are prefilled or multidose pen-based drug delivery devices designed to administer GLP-1 receptor agonists or related incretin therapies through subcutaneous injection, mainly for diabetes and obesity treatment. They combine a high-value biologic or peptide drug with a user-friendly injection mechanism, enabling patients to self-administer weekly or daily doses with lower handling complexity than vial-and-syringe injection. In 2025, Global GLP-1 autoinjector sales are estimated at about 1,350 million units, with an average ex-works device value of about US$3.2 per unit. The industry chain runs from medical-grade polymers, springs, needles, glass cartridges/syringes and precision molds to pen injector design, device assembly, sterile filling, pharmaceutical combination-product registration, and diabetes/obesity drug distribution.

Demand is mainly driven by the rapid expansion of GLP-1 therapies from diabetes into chronic weight management, the shift of obesity treatment toward long-term self-administered medication, and patients' preference for convenient home injection. Supply-side growth is also reinforced by pharmaceutical companies? need to reduce device-related bottlenecks, improve dose adherence, differentiate branded drugs through usability, and secure large-scale dual-sourcing capacity for high-volume GLP-1 launches.

LP Information, Inc. (LPI) ' newest research report, the ?GLP-1 Autoinjectors Industry Forecast? looks at past sales and reviews total world GLP-1 Autoinjectors sales in 2025, providing a comprehensive analysis by region and market sector of projected GLP-1 Autoinjectors sales for 2026 through 2032. With GLP-1 Autoinjectors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Autoinjectors industry.

This Insight Report provides a comprehensive analysis of the global GLP-1 Autoinjectors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 Autoinjectors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global GLP-1 Autoinjectors market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Autoinjectors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Autoinjectors.

This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Autoinjectors market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Fixed-Dose Autoinjector
  • Multidose Pen Injector
  • Dose-Selectable Pen
Segmentation by Use Cycle:
  • Single-Use Disposable
  • Reusable Base with Replaceable Cartridge
Segmentation by Therapeutic Indication:
  • Obesity Treatment
  • Type 2 Diabetes
  • Others
Segmentation by Application:
  • Pharmaceutical
  • CDMO
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Novo Nordisk
  • Eli Lilly and Company
  • Sanofi
  • Ypsomed
  • SHL Medical
  • Gerresheimer
  • Stevanato Group
  • Owen Mumford
  • Phillips-Medisize
  • Nemera
  • Haselmeier
  • medmix
  • Bespak
  • Becton Dickinson
  • Terumo
Key Questions Addressed in this Report
What is the 10-year outlook for the global GLP-1 Autoinjectors market?
What factors are driving GLP-1 Autoinjectors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GLP-1 Autoinjectors market opportunities vary by end market size?
How does GLP-1 Autoinjectors break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global GLP-1 Autoinjectors Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for GLP-1 Autoinjectors by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for GLP-1 Autoinjectors by Country/Region, 2021, 2025 & 2032
2.2 GLP-1 Autoinjectors Segment by Type
  2.2.1 Fixed-Dose Autoinjector
  2.2.2 Multidose Pen Injector
  2.2.3 Dose-Selectable Pen
  2.2.4 GLP-1 Autoinjectors Sales by Type
    2.2.4.1 Global GLP-1 Autoinjectors Sales Market Share by Type (2021-2026)
    2.2.4.2 Global GLP-1 Autoinjectors Revenue and Market Share by Type (2021-2026)
    2.2.4.3 Global GLP-1 Autoinjectors Sale Price by Type (2021-2026)
2.3 GLP-1 Autoinjectors Segment by Use Cycle
  2.3.1 Single-Use Disposable
  2.3.2 Reusable Base with Replaceable Cartridge
  2.3.3 GLP-1 Autoinjectors Sales by Use Cycle
    2.3.3.1 Global GLP-1 Autoinjectors Sales Market Share by Use Cycle (2021-2026)
    2.3.3.2 Global GLP-1 Autoinjectors Revenue and Market Share by Use Cycle (2021-2026)
    2.3.3.3 Global GLP-1 Autoinjectors Sale Price by Use Cycle (2021-2026)
2.4 GLP-1 Autoinjectors Segment by Therapeutic Indication
  2.4.1 Obesity Treatment
  2.4.2 Type 2 Diabetes
  2.4.3 Others
  2.4.4 GLP-1 Autoinjectors Sales by Therapeutic Indication
    2.4.4.1 Global GLP-1 Autoinjectors Sales Market Share by Therapeutic Indication (2021-2026)
    2.4.4.2 Global GLP-1 Autoinjectors Revenue and Market Share by Therapeutic Indication (2021-2026)
    2.4.4.3 Global GLP-1 Autoinjectors Sale Price by Therapeutic Indication (2021-2026)
2.5 GLP-1 Autoinjectors Segment by Application
  2.5.1 Pharmaceutical
  2.5.2 CDMO
  2.5.3 Others
  2.5.4 GLP-1 Autoinjectors Sales by Application
    2.5.4.1 Global GLP-1 Autoinjectors Sale Market Share by Application (2021-2026)
    2.5.4.2 Global GLP-1 Autoinjectors Revenue and Market Share by Application (2021-2026)
    2.5.4.3 Global GLP-1 Autoinjectors Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global GLP-1 Autoinjectors Breakdown Data by Company
  3.1.1 Global GLP-1 Autoinjectors Annual Sales by Company (2021-2026)
  3.1.2 Global GLP-1 Autoinjectors Sales Market Share by Company (2021-2026)
3.2 Global GLP-1 Autoinjectors Annual Revenue by Company (2021-2026)
  3.2.1 Global GLP-1 Autoinjectors Revenue by Company (2021-2026)
  3.2.2 Global GLP-1 Autoinjectors Revenue Market Share by Company (2021-2026)
3.3 Global GLP-1 Autoinjectors Sale Price by Company
3.4 Key Manufacturers GLP-1 Autoinjectors Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers GLP-1 Autoinjectors Product Location Distribution
  3.4.2 Players GLP-1 Autoinjectors Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR GLP-1 AUTOINJECTORS BY GEOGRAPHIC REGION

4.1 World Historic GLP-1 Autoinjectors Market Size by Geographic Region (2021-2026)
  4.1.1 Global GLP-1 Autoinjectors Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global GLP-1 Autoinjectors Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic GLP-1 Autoinjectors Market Size by Country/Region (2021-2026)
  4.2.1 Global GLP-1 Autoinjectors Annual Sales by Country/Region (2021-2026)
  4.2.2 Global GLP-1 Autoinjectors Annual Revenue by Country/Region (2021-2026)
4.3 Americas GLP-1 Autoinjectors Sales Growth
4.4 APAC GLP-1 Autoinjectors Sales Growth
4.5 Europe GLP-1 Autoinjectors Sales Growth
4.6 Middle East & Africa GLP-1 Autoinjectors Sales Growth

5 AMERICAS

5.1 Americas GLP-1 Autoinjectors Sales by Country
  5.1.1 Americas GLP-1 Autoinjectors Sales by Country (2021-2026)
  5.1.2 Americas GLP-1 Autoinjectors Revenue by Country (2021-2026)
5.2 Americas GLP-1 Autoinjectors Sales by Type (2021-2026)
5.3 Americas GLP-1 Autoinjectors Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC GLP-1 Autoinjectors Sales by Region
  6.1.1 APAC GLP-1 Autoinjectors Sales by Region (2021-2026)
  6.1.2 APAC GLP-1 Autoinjectors Revenue by Region (2021-2026)
6.2 APAC GLP-1 Autoinjectors Sales by Type (2021-2026)
6.3 APAC GLP-1 Autoinjectors Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe GLP-1 Autoinjectors by Country
  7.1.1 Europe GLP-1 Autoinjectors Sales by Country (2021-2026)
  7.1.2 Europe GLP-1 Autoinjectors Revenue by Country (2021-2026)
7.2 Europe GLP-1 Autoinjectors Sales by Type (2021-2026)
7.3 Europe GLP-1 Autoinjectors Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa GLP-1 Autoinjectors by Country
  8.1.1 Middle East & Africa GLP-1 Autoinjectors Sales by Country (2021-2026)
  8.1.2 Middle East & Africa GLP-1 Autoinjectors Revenue by Country (2021-2026)
8.2 Middle East & Africa GLP-1 Autoinjectors Sales by Type (2021-2026)
8.3 Middle East & Africa GLP-1 Autoinjectors Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Autoinjectors
10.3 Manufacturing Process Analysis of GLP-1 Autoinjectors
10.4 Industry Chain Structure of GLP-1 Autoinjectors

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 GLP-1 Autoinjectors Distributors
11.3 GLP-1 Autoinjectors Customer

12 WORLD FORECAST REVIEW FOR GLP-1 AUTOINJECTORS BY GEOGRAPHIC REGION

12.1 Global GLP-1 Autoinjectors Market Size Forecast by Region
  12.1.1 Global GLP-1 Autoinjectors Forecast by Region (2027-2032)
  12.1.2 Global GLP-1 Autoinjectors Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global GLP-1 Autoinjectors Forecast by Type (2027-2032)
12.7 Global GLP-1 Autoinjectors Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Novo Nordisk
  13.1.1 Novo Nordisk Company Information
  13.1.2 Novo Nordisk GLP-1 Autoinjectors Product Portfolios and Specifications
  13.1.3 Novo Nordisk GLP-1 Autoinjectors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Novo Nordisk Main Business Overview
  13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly and Company
  13.2.1 Eli Lilly and Company Company Information
  13.2.2 Eli Lilly and Company GLP-1 Autoinjectors Product Portfolios and Specifications
  13.2.3 Eli Lilly and Company GLP-1 Autoinjectors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Eli Lilly and Company Main Business Overview
  13.2.5 Eli Lilly and Company Latest Developments
13.3 Sanofi
  13.3.1 Sanofi Company Information
  13.3.2 Sanofi GLP-1 Autoinjectors Product Portfolios and Specifications
  13.3.3 Sanofi GLP-1 Autoinjectors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Sanofi Main Business Overview
  13.3.5 Sanofi Latest Developments
13.4 Ypsomed
  13.4.1 Ypsomed Company Information
  13.4.2 Ypsomed GLP-1 Autoinjectors Product Portfolios and Specifications
  13.4.3 Ypsomed GLP-1 Autoinjectors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Ypsomed Main Business Overview
  13.4.5 Ypsomed Latest Developments
13.5 SHL Medical
  13.5.1 SHL Medical Company Information
  13.5.2 SHL Medical GLP-1 Autoinjectors Product Portfolios and Specifications
  13.5.3 SHL Medical GLP-1 Autoinjectors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 SHL Medical Main Business Overview
  13.5.5 SHL Medical Latest Developments
13.6 Gerresheimer
  13.6.1 Gerresheimer Company Information
  13.6.2 Gerresheimer GLP-1 Autoinjectors Product Portfolios and Specifications
  13.6.3 Gerresheimer GLP-1 Autoinjectors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Gerresheimer Main Business Overview
  13.6.5 Gerresheimer Latest Developments
13.7 Stevanato Group
  13.7.1 Stevanato Group Company Information
  13.7.2 Stevanato Group GLP-1 Autoinjectors Product Portfolios and Specifications
  13.7.3 Stevanato Group GLP-1 Autoinjectors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Stevanato Group Main Business Overview
  13.7.5 Stevanato Group Latest Developments
13.8 Owen Mumford
  13.8.1 Owen Mumford Company Information
  13.8.2 Owen Mumford GLP-1 Autoinjectors Product Portfolios and Specifications
  13.8.3 Owen Mumford GLP-1 Autoinjectors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Owen Mumford Main Business Overview
  13.8.5 Owen Mumford Latest Developments
13.9 Phillips-Medisize
  13.9.1 Phillips-Medisize Company Information
  13.9.2 Phillips-Medisize GLP-1 Autoinjectors Product Portfolios and Specifications
  13.9.3 Phillips-Medisize GLP-1 Autoinjectors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Phillips-Medisize Main Business Overview
  13.9.5 Phillips-Medisize Latest Developments
13.10 Nemera
  13.10.1 Nemera Company Information
  13.10.2 Nemera GLP-1 Autoinjectors Product Portfolios and Specifications
  13.10.3 Nemera GLP-1 Autoinjectors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Nemera Main Business Overview
  13.10.5 Nemera Latest Developments
13.11 Haselmeier
  13.11.1 Haselmeier Company Information
  13.11.2 Haselmeier GLP-1 Autoinjectors Product Portfolios and Specifications
  13.11.3 Haselmeier GLP-1 Autoinjectors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Haselmeier Main Business Overview
  13.11.5 Haselmeier Latest Developments
13.12 medmix
  13.12.1 medmix Company Information
  13.12.2 medmix GLP-1 Autoinjectors Product Portfolios and Specifications
  13.12.3 medmix GLP-1 Autoinjectors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 medmix Main Business Overview
  13.12.5 medmix Latest Developments
13.13 Bespak
  13.13.1 Bespak Company Information
  13.13.2 Bespak GLP-1 Autoinjectors Product Portfolios and Specifications
  13.13.3 Bespak GLP-1 Autoinjectors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Bespak Main Business Overview
  13.13.5 Bespak Latest Developments
13.14 Becton Dickinson
  13.14.1 Becton Dickinson Company Information
  13.14.2 Becton Dickinson GLP-1 Autoinjectors Product Portfolios and Specifications
  13.14.3 Becton Dickinson GLP-1 Autoinjectors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 Becton Dickinson Main Business Overview
  13.14.5 Becton Dickinson Latest Developments
13.15 Terumo
  13.15.1 Terumo Company Information
  13.15.2 Terumo GLP-1 Autoinjectors Product Portfolios and Specifications
  13.15.3 Terumo GLP-1 Autoinjectors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.15.4 Terumo Main Business Overview
  13.15.5 Terumo Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. GLP-1 Autoinjectors Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. GLP-1 Autoinjectors Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fixed-Dose Autoinjector
Table 4. Major Players of Multidose Pen Injector
Table 5. Major Players of Dose-Selectable Pen
Table 6. Global GLP-1 Autoinjectors Sales by Type (2021-2026) & (million Units)
Table 7. Global GLP-1 Autoinjectors Sales Market Share by Type (2021-2026)
Table 8. Global GLP-1 Autoinjectors Revenue by Type (2021-2026) & ($ million)
Table 9. Global GLP-1 Autoinjectors Revenue Market Share by Type (2021-2026)
Table 10. Global GLP-1 Autoinjectors Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Single-Use Disposable
Table 12. Major Players of Reusable Base with Replaceable Cartridge
Table 13. Global GLP-1 Autoinjectors Sales by Use Cycle (2021-2026) & (million Units)
Table 14. Global GLP-1 Autoinjectors Sales Market Share by Use Cycle (2021-2026)
Table 15. Global GLP-1 Autoinjectors Revenue by Use Cycle (2021-2026) & ($ million)
Table 16. Global GLP-1 Autoinjectors Revenue Market Share by Use Cycle (2021-2026)
Table 17. Global GLP-1 Autoinjectors Sale Price by Use Cycle (2021-2026) & (US$/Unit)
Table 18. Major Players of Obesity Treatment
Table 19. Major Players of Type 2 Diabetes
Table 20. Major Players of Others
Table 21. Global GLP-1 Autoinjectors Sales by Therapeutic Indication (2021-2026) & (million Units)
Table 22. Global GLP-1 Autoinjectors Sales Market Share by Therapeutic Indication (2021-2026)
Table 23. Global GLP-1 Autoinjectors Revenue by Therapeutic Indication (2021-2026) & ($ million)
Table 24. Global GLP-1 Autoinjectors Revenue Market Share by Therapeutic Indication (2021-2026)
Table 25. Global GLP-1 Autoinjectors Sale Price by Therapeutic Indication (2021-2026) & (US$/Unit)
Table 26. Global GLP-1 Autoinjectors Sale by Application (2021-2026) & (million Units)
Table 27. Global GLP-1 Autoinjectors Sale Market Share by Application (2021-2026)
Table 28. Global GLP-1 Autoinjectors Revenue by Application (2021-2026) & ($ million)
Table 29. Global GLP-1 Autoinjectors Revenue Market Share by Application (2021-2026)
Table 30. Global GLP-1 Autoinjectors Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global GLP-1 Autoinjectors Sales by Company (2021-2026) & (million Units)
Table 32. Global GLP-1 Autoinjectors Sales Market Share by Company (2021-2026)
Table 33. Global GLP-1 Autoinjectors Revenue by Company (2021-2026) & ($ millions)
Table 34. Global GLP-1 Autoinjectors Revenue Market Share by Company (2021-2026)
Table 35. Global GLP-1 Autoinjectors Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers GLP-1 Autoinjectors Producing Area Distribution and Sales Area
Table 37. Players GLP-1 Autoinjectors Products Offered
Table 38. GLP-1 Autoinjectors Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global GLP-1 Autoinjectors Sales by Geographic Region (2021-2026) & (million Units)
Table 42. Global GLP-1 Autoinjectors Sales Market Share Geographic Region (2021-2026)
Table 43. Global GLP-1 Autoinjectors Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global GLP-1 Autoinjectors Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global GLP-1 Autoinjectors Sales by Country/Region (2021-2026) & (million Units)
Table 46. Global GLP-1 Autoinjectors Sales Market Share by Country/Region (2021-2026)
Table 47. Global GLP-1 Autoinjectors Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global GLP-1 Autoinjectors Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas GLP-1 Autoinjectors Sales by Country (2021-2026) & (million Units)
Table 50. Americas GLP-1 Autoinjectors Sales Market Share by Country (2021-2026)
Table 51. Americas GLP-1 Autoinjectors Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas GLP-1 Autoinjectors Sales by Type (2021-2026) & (million Units)
Table 53. Americas GLP-1 Autoinjectors Sales by Application (2021-2026) & (million Units)
Table 54. APAC GLP-1 Autoinjectors Sales by Region (2021-2026) & (million Units)
Table 55. APAC GLP-1 Autoinjectors Sales Market Share by Region (2021-2026)
Table 56. APAC GLP-1 Autoinjectors Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC GLP-1 Autoinjectors Sales by Type (2021-2026) & (million Units)
Table 58. APAC GLP-1 Autoinjectors Sales by Application (2021-2026) & (million Units)
Table 59. Europe GLP-1 Autoinjectors Sales by Country (2021-2026) & (million Units)
Table 60. Europe GLP-1 Autoinjectors Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe GLP-1 Autoinjectors Sales by Type (2021-2026) & (million Units)
Table 62. Europe GLP-1 Autoinjectors Sales by Application (2021-2026) & (million Units)
Table 63. Middle East & Africa GLP-1 Autoinjectors Sales by Country (2021-2026) & (million Units)
Table 64. Middle East & Africa GLP-1 Autoinjectors Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa GLP-1 Autoinjectors Sales by Type (2021-2026) & (million Units)
Table 66. Middle East & Africa GLP-1 Autoinjectors Sales by Application (2021-2026) & (million Units)
Table 67. Key Market Drivers & Growth Opportunities of GLP-1 Autoinjectors
Table 68. Key Market Challenges & Risks of GLP-1 Autoinjectors
Table 69. Key Industry Trends of GLP-1 Autoinjectors
Table 70. GLP-1 Autoinjectors Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. GLP-1 Autoinjectors Distributors List
Table 73. GLP-1 Autoinjectors Customer List
Table 74. Global GLP-1 Autoinjectors Sales Forecast by Region (2027-2032) & (million Units)
Table 75. Global GLP-1 Autoinjectors Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas GLP-1 Autoinjectors Sales Forecast by Country (2027-2032) & (million Units)
Table 77. Americas GLP-1 Autoinjectors Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC GLP-1 Autoinjectors Sales Forecast by Region (2027-2032) & (million Units)
Table 79. APAC GLP-1 Autoinjectors Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe GLP-1 Autoinjectors Sales Forecast by Country (2027-2032) & (million Units)
Table 81. Europe GLP-1 Autoinjectors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa GLP-1 Autoinjectors Sales Forecast by Country (2027-2032) & (million Units)
Table 83. Middle East & Africa GLP-1 Autoinjectors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global GLP-1 Autoinjectors Sales Forecast by Type (2027-2032) & (million Units)
Table 85. Global GLP-1 Autoinjectors Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global GLP-1 Autoinjectors Sales Forecast by Application (2027-2032) & (million Units)
Table 87. Global GLP-1 Autoinjectors Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Novo Nordisk Basic Information, GLP-1 Autoinjectors Manufacturing Base, Sales Area and Its Competitors
Table 89. Novo Nordisk GLP-1 Autoinjectors Product Portfolios and Specifications
Table 90. Novo Nordisk GLP-1 Autoinjectors Sales (million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Novo Nordisk Main Business
Table 92. Novo Nordisk Latest Developments
Table 93. Eli Lilly and Company Basic Information, GLP-1 Autoinjectors Manufacturing Base, Sales Area and Its Competitors
Table 94. Eli Lilly and Company GLP-1 Autoinjectors Product Portfolios and Specifications
Table 95. Eli Lilly and Company GLP-1 Autoinjectors Sales (million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Eli Lilly and Company Main Business
Table 97. Eli Lilly and Company Latest Developments
Table 98. Sanofi Basic Information, GLP-1 Autoinjectors Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi GLP-1 Autoinjectors Product Portfolios and Specifications
Table 100. Sanofi GLP-1 Autoinjectors Sales (million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Sanofi Main Business
Table 102. Sanofi Latest Developments
Table 103. Ypsomed Basic Information, GLP-1 Autoinjectors Manufacturing Base, Sales Area and Its Competitors
Table 104. Ypsomed GLP-1 Autoinjectors Product Portfolios and Specifications
Table 105. Ypsomed GLP-1 Autoinjectors Sales (million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Ypsomed Main Business
Table 107. Ypsomed Latest Developments
Table 108. SHL Medical Basic Information, GLP-1 Autoinjectors Manufacturing Base, Sales Area and Its Competitors
Table 109. SHL Medical GLP-1 Autoinjectors Product Portfolios and Specifications
Table 110. SHL Medical GLP-1 Autoinjectors Sales (million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. SHL Medical Main Business
Table 112. SHL Medical Latest Developments
Table 113. Gerresheimer Basic Information, GLP-1 Autoinjectors Manufacturing Base, Sales Area and Its Competitors
Table 114. Gerresheimer GLP-1 Autoinjectors Product Portfolios and Specifications
Table 115. Gerresheimer GLP-1 Autoinjectors Sales (million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Gerresheimer Main Business
Table 117. Gerresheimer Latest Developments
Table 118. Stevanato Group Basic Information, GLP-1 Autoinjectors Manufacturing Base, Sales Area and Its Competitors
Table 119. Stevanato Group GLP-1 Autoinjectors Product Portfolios and Specifications
Table 120. Stevanato Group GLP-1 Autoinjectors Sales (million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Stevanato Group Main Business
Table 122. Stevanato Group Latest Developments
Table 123. Owen Mumford Basic Information, GLP-1 Autoinjectors Manufacturing Base, Sales Area and Its Competitors
Table 124. Owen Mumford GLP-1 Autoinjectors Product Portfolios and Specifications
Table 125. Owen Mumford GLP-1 Autoinjectors Sales (million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Owen Mumford Main Business
Table 127. Owen Mumford Latest Developments
Table 128. Phillips-Medisize Basic Information, GLP-1 Autoinjectors Manufacturing Base, Sales Area and Its Competitors
Table 129. Phillips-Medisize GLP-1 Autoinjectors Product Portfolios and Specifications
Table 130. Phillips-Medisize GLP-1 Autoinjectors Sales (million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Phillips-Medisize Main Business
Table 132. Phillips-Medisize Latest Developments
Table 133. Nemera Basic Information, GLP-1 Autoinjectors Manufacturing Base, Sales Area and Its Competitors
Table 134. Nemera GLP-1 Autoinjectors Product Portfolios and Specifications
Table 135. Nemera GLP-1 Autoinjectors Sales (million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Nemera Main Business
Table 137. Nemera Latest Developments
Table 138. Haselmeier Basic Information, GLP-1 Autoinjectors Manufacturing Base, Sales Area and Its Competitors
Table 139. Haselmeier GLP-1 Autoinjectors Product Portfolios and Specifications
Table 140. Haselmeier GLP-1 Autoinjectors Sales (million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Haselmeier Main Business
Table 142. Haselmeier Latest Developments
Table 143. medmix Basic Information, GLP-1 Autoinjectors Manufacturing Base, Sales Area and Its Competitors
Table 144. medmix GLP-1 Autoinjectors Product Portfolios and Specifications
Table 145. medmix GLP-1 Autoinjectors Sales (million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. medmix Main Business
Table 147. medmix Latest Developments
Table 148. Bespak Basic Information, GLP-1 Autoinjectors Manufacturing Base, Sales Area and Its Competitors
Table 149. Bespak GLP-1 Autoinjectors Product Portfolios and Specifications
Table 150. Bespak GLP-1 Autoinjectors Sales (million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Bespak Main Business
Table 152. Bespak Latest Developments
Table 153. Becton Dickinson Basic Information, GLP-1 Autoinjectors Manufacturing Base, Sales Area and Its Competitors
Table 154. Becton Dickinson GLP-1 Autoinjectors Product Portfolios and Specifications
Table 155. Becton Dickinson GLP-1 Autoinjectors Sales (million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Becton Dickinson Main Business
Table 157. Becton Dickinson Latest Developments
Table 158. Terumo Basic Information, GLP-1 Autoinjectors Manufacturing Base, Sales Area and Its Competitors
Table 159. Terumo GLP-1 Autoinjectors Product Portfolios and Specifications
Table 160. Terumo GLP-1 Autoinjectors Sales (million Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Terumo Main Business
Table 162. Terumo Latest Developments

LIST OF FIGURES

Figure 1. Picture of GLP-1 Autoinjectors
Figure 2. GLP-1 Autoinjectors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Autoinjectors Sales Growth Rate 2021-2032 (million Units)
Figure 7. Global GLP-1 Autoinjectors Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. GLP-1 Autoinjectors Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. GLP-1 Autoinjectors Sales Market Share by Country/Region (2025)
Figure 10. GLP-1 Autoinjectors Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Fixed-Dose Autoinjector
Figure 12. Product Picture of Multidose Pen Injector
Figure 13. Product Picture of Dose-Selectable Pen
Figure 14. Global GLP-1 Autoinjectors Sales Market Share by Type in 2026
Figure 15. Global GLP-1 Autoinjectors Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Single-Use Disposable
Figure 17. Product Picture of Reusable Base with Replaceable Cartridge
Figure 18. Global GLP-1 Autoinjectors Sales Market Share by Use Cycle in 2026
Figure 19. Global GLP-1 Autoinjectors Revenue Market Share by Use Cycle (2021-2026)
Figure 20. Product Picture of Obesity Treatment
Figure 21. Product Picture of Type 2 Diabetes
Figure 22. Product Picture of Others
Figure 23. Global GLP-1 Autoinjectors Sales Market Share by Therapeutic Indication in 2026
Figure 24. Global GLP-1 Autoinjectors Revenue Market Share by Therapeutic Indication (2021-2026)
Figure 25. GLP-1 Autoinjectors Consumed in Pharmaceutical
Figure 26. Global GLP-1 Autoinjectors Market: Pharmaceutical (2021-2026) & (million Units)
Figure 27. GLP-1 Autoinjectors Consumed in CDMO
Figure 28. Global GLP-1 Autoinjectors Market: CDMO (2021-2026) & (million Units)
Figure 29. GLP-1 Autoinjectors Consumed in Others
Figure 30. Global GLP-1 Autoinjectors Market: Others (2021-2026) & (million Units)
Figure 31. Global GLP-1 Autoinjectors Sale Market Share by Application (2025)
Figure 32. Global GLP-1 Autoinjectors Revenue Market Share by Application in 2025
Figure 33. GLP-1 Autoinjectors Sales by Company in 2025 (million Units)
Figure 34. Global GLP-1 Autoinjectors Sales Market Share by Company in 2025
Figure 35. GLP-1 Autoinjectors Revenue by Company in 2025 ($ millions)
Figure 36. Global GLP-1 Autoinjectors Revenue Market Share by Company in 2025
Figure 37. Global GLP-1 Autoinjectors Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global GLP-1 Autoinjectors Revenue Market Share by Geographic Region in 2025
Figure 39. Americas GLP-1 Autoinjectors Sales 2021-2026 (million Units)
Figure 40. Americas GLP-1 Autoinjectors Revenue 2021-2026 ($ millions)
Figure 41. APAC GLP-1 Autoinjectors Sales 2021-2026 (million Units)
Figure 42. APAC GLP-1 Autoinjectors Revenue 2021-2026 ($ millions)
Figure 43. Europe GLP-1 Autoinjectors Sales 2021-2026 (million Units)
Figure 44. Europe GLP-1 Autoinjectors Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa GLP-1 Autoinjectors Sales 2021-2026 (million Units)
Figure 46. Middle East & Africa GLP-1 Autoinjectors Revenue 2021-2026 ($ millions)
Figure 47. Americas GLP-1 Autoinjectors Sales Market Share by Country in 2025
Figure 48. Americas GLP-1 Autoinjectors Revenue Market Share by Country (2021-2026)
Figure 49. Americas GLP-1 Autoinjectors Sales Market Share by Type (2021-2026)
Figure 50. Americas GLP-1 Autoinjectors Sales Market Share by Application (2021-2026)
Figure 51. United States GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC GLP-1 Autoinjectors Sales Market Share by Region in 2025
Figure 56. APAC GLP-1 Autoinjectors Revenue Market Share by Region (2021-2026)
Figure 57. APAC GLP-1 Autoinjectors Sales Market Share by Type (2021-2026)
Figure 58. APAC GLP-1 Autoinjectors Sales Market Share by Application (2021-2026)
Figure 59. China GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 63. India GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe GLP-1 Autoinjectors Sales Market Share by Country in 2025
Figure 67. Europe GLP-1 Autoinjectors Revenue Market Share by Country (2021-2026)
Figure 68. Europe GLP-1 Autoinjectors Sales Market Share by Type (2021-2026)
Figure 69. Europe GLP-1 Autoinjectors Sales Market Share by Application (2021-2026)
Figure 70. Germany GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 71. France GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 72. UK GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa GLP-1 Autoinjectors Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa GLP-1 Autoinjectors Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa GLP-1 Autoinjectors Sales Market Share by Application (2021-2026)
Figure 78. Egypt GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries GLP-1 Autoinjectors Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of GLP-1 Autoinjectors in 2026
Figure 84. Manufacturing Process Analysis of GLP-1 Autoinjectors
Figure 85. Industry Chain Structure of GLP-1 Autoinjectors
Figure 86. Channels of Distribution
Figure 87. Global GLP-1 Autoinjectors Sales Market Forecast by Region (2027-2032)
Figure 88. Global GLP-1 Autoinjectors Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global GLP-1 Autoinjectors Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global GLP-1 Autoinjectors Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global GLP-1 Autoinjectors Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global GLP-1 Autoinjectors Revenue Market Share Forecast by Application (2027-2032)


More Publications